Gene: UBTD2
Official Full Name: ubiquitin domain containing 2provided by HGNC
Gene Summary: Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23240 | UBTD2 Knockout cell line (HeLa) | Human | UBTD2 | 1:3~1:6 | Negative | Online Inquiry |
KO23241 | UBTD2 Knockout cell line (HCT 116) | Human | UBTD2 | 1:2~1:4 | Negative | Online Inquiry |
KO23242 | UBTD2 Knockout cell line (HEK293) | Human | UBTD2 | 1:3~1:6 | Negative | Online Inquiry |
KO23243 | UBTD2 Knockout cell line (A549) | Human | UBTD2 | 1:3~1:4 | Negative | Online Inquiry |
UBTD2 Gene Knockout Cell Lines represent a cutting-edge tool in cellular and molecular biology, designed to facilitate the study of gene function and cellular pathways associated with the UBTD2 gene. These cell lines are engineered via targeted genome editing techniques, specifically CRISPR/Cas9, to create mutations that effectively disable the UBTD2 gene's function. The knockout of UBTD2 allows researchers to explore its role in ubiquitination processes, protein degradation pathways, and implications in various diseases, notably cancer.
The primary mechanism by which these cell lines operate involves the absence of UBTD2 protein, leading to a cascade of biochemical changes that can affect signal transduction, cell cycle regulation, and apoptosis pathways. By utilizing these knockout models, scientists can conduct in-depth analysis to elucidate the gene's contributions to cellular homeostasis and its possible aberrations in pathophysiological conditions. Research applications span from fundamental biological studies to the development of therapeutic interventions, providing insights that are critical for advancing personalized medicine.
What sets UBTD2 Gene Knockout Cell Lines apart from conventional models is their unparalleled specificity and precision. Traditional approaches, including pharmacological inhibition or transgenic systems, often yield non-specific effects or compensatory mechanisms that can complicate results. In contrast, knockout cell lines offer a stable, reproducible, and unambiguous background for experiments, enabling precise assessment of the effects of UBTD2 loss.
For researchers and clinicians alike, the UBTD2 Gene Knockout Cell Lines are an invaluable resource, enhancing experimental rigor and aiding in the translation of fundamental research into clinical applications. Utilizing these models can significantly accelerate the pace of discovery, presenting opportunities to unravel complex biological networks and identify novel therapeutic targets.
Our company is dedicated to advancing scientific research and innovation. With expertise in genetic engineering and cell line development, we provide high-quality biological products that meet the rigorous demands of the research community, ensuring researchers have the tools needed to push the boundaries of knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.